UI
UNIFI INC (UFI)·Q4 2024 Earnings Summary
Executive Summary
- Q4 FY2024 net sales were $157.5M, up 6% sequentially and 4% YoY; gross margin improved to 6.9% (third consecutive quarterly improvement), and Adjusted EBITDA turned positive to $5.9M; GAAP EPS was $(0.22) .
- REPREVE Fiber revenue rose to $53.6M (34% of sales) from $46.8M (31%) in Q3, reflecting momentum in Central America and moderating recovery in Asia .
- FY2025 outlook: net sales to grow >10% YoY, with significant increases in gross profit, margin, and Adjusted EBITDA; Q1 FY2025 guidance: net sales $147–$153M, Adjusted EBITDA $1–$3M, capex $3–$4M; effective tax rate volatility to persist .
- Stock reaction catalyst: sequential margin recovery, positive FY2025 profitability trajectory, and new circular REPREVE products (white filament yarn and ThermaLoop insulation) that target higher-margin “beyond apparel” use cases; note Q4 net sales were modestly below the prior $160–$165M guidance range while Adjusted EBITDA met the $4–$6M guide .
What Went Well and What Went Wrong
What Went Well
- REPREVE mix expansion and segment strength: REPREVE contribution rose to 34% of sales; Brazil delivered strong pricing, full utilization, and market share gains; Asia net sales grew 21% QoQ .
- Cost reset and margin expansion: third straight quarter of gross profit improvement; consolidated gross margin expanded to 6.9%; EBITDA positive; management cites durable efficiencies despite some inflation headwinds .
- Innovation pipeline and “beyond apparel”: launch of circular white filament yarn and ThermaLoop insulation, with expected revenue starting in H2 FY2025 (filament) and FY2026 (ThermaLoop); management emphasized stronger margin profile than base apparel .
What Went Wrong
- Americas remained soft: net sales were flat sequentially and down 4% YoY; customers pushed out orders; Americas segment gross profit only breakeven .
- Q4 net sales missed prior guidance range: delivered $157.5M vs the Q3 guide of $160–$165M, though Adjusted EBITDA landed within the $4–$6M range at $5.9M .
- Ongoing tax-rate volatility and cautious macro: management flagged continued volatility in effective tax rate and sluggish consumer trends; raw material/freight costs in Brazil rising, partly offset by pricing .
Financial Results
Consolidated Performance vs Prior Year, Prior Quarter, and Guidance
Segment Breakdown
KPIs and Cash/Leverage
Guidance vs Actual (Q4 FY2024)
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “We are pleased to close our fiscal 2024 with growing momentum... our financial performance over the last few quarters has shown consistent top-line growth, and we reported our third consecutive quarter of gross profit improvement.” — Eddie Ingle, CEO .
- “Our EBITDA was $5.9 million... attributed mostly to these quarter 2 and quarter 3 cost reductions... most of those cost reductions are now fully in place.” — Al Carey, Executive Chairman .
- “During the fourth quarter, REPREVE represented 34% of sales... we believe we will see additional improvements in our REPREVE Fiber business as we progress through fiscal 2025.” — Eddie Ingle, CEO .
- “CapEx spend continues to be focused on maintenance levels... with fiscal 2024 coming in at $11 million, a multiyear low.” — A.J. Eaker, CFO .
- “We believe we will begin to see revenue... from our new filament yarn in the second half of fiscal 2025 and... growth benefits from ThermaLoop throughout fiscal 2026.” — Eddie Ingle, CEO .
Q&A Highlights
- Brazil sustainability: Management expects Brazil to run full throughout FY2025; margins may compress as input costs normalize, but EBITDA to improve YoY .
- Cost dynamics: Freight/container costs rising in Brazil; raw materials largely flat in other regions .
- Demand timing: Top customers signaling slower July–September (seasonal) with expected improvement from October; Central America already improving .
- New products scale/margins: Management expects meaningful production orders in late FY2025 and visibility in FY2026; margins on new products are “double” base business in many cases .
- Beyond apparel traction: Commercial orders underway; revenue impacts expected to be outlined in next call; higher margins than base apparel .
Estimates Context
- S&P Global consensus for Q4 FY2024 EPS/revenue/EBITDA was unavailable in our session due to data access limits; therefore, estimate comparisons cannot be provided for this quarter (Wall Street consensus via S&P Global unavailable) [GetEstimates error].
- We note company-issued Q4 guidance was $160–$165M net sales and $4–$6M Adjusted EBITDA; actuals came in at $157.5M and $5.9M, respectively, implying a modest revenue shortfall with EBITDA within expectations .
Key Takeaways for Investors
- Sequential recovery with cleaner execution: Three consecutive quarters of gross profit improvement and a Q4 EBITDA inflection support FY2025 profitability momentum; focus on disciplined capex and working capital should underpin FCF stabilization .
- Mix tailwind from REPREVE and innovations: REPREVE mix rose to 34% with new circular products slated to begin contributing in H2 FY2025/FY2026, offering margin-accretive growth beyond apparel .
- Regional dispersion: Brazil and Asia are leading the recovery; Americas remains the swing factor—watch order timing and competitive dynamics into Q1/Q2 FY2025 for confirmation of a broader demand normalization .
- Near-term setup: Q1 FY2025 guide implies continued progress but seasonally softer quarter; monitor execution on pricing, utilization, and cost control to sustain margin gains despite tax-rate volatility .
- Medium-term thesis: If >10% FY2025 top-line growth materializes alongside structural cost resets and higher-margin product mix, the earnings power could reset higher; new product adoption and regulatory sustainability tailwinds are incremental positives .
- Risk checks: Freight and raw-material cost variability (especially in Brazil), cautious consumer, and timing of customer replenishment remain key risks to near-term topline trajectory .
- Actionable: Track quarterly REPREVE mix, segment margins, and commercialization milestones for white filament/ThermaLoop; a beat on Q1 FY2025 Adjusted EBITDA and confirmation of Americas demand normalization would be a positive catalyst .